The results indicate that reduced DcR3 could greatly enhance the proapoptotic effect of TRAIL in these 2 pancreatic cancer cell lines (as compared to FasL and LIGHT), whereas DcR3 is utilized by these cells to counteract the proapoptotic effect of TRAIL. This evidence concerns the gene TNFSF10 and pancreatic neoplasm.